전립선암의 남성호르몬 박탈 치료와 근치적 전립선적출술의 비용 분석 = Cost Comparison of Androgen Deprivation Therapy and Radical Prostatectomy for Prostate Cancer1)

국문 초록 (Abstract)

Purposes: 본 연구는 전립선암 환자의 의료비 지출을 평가하기 위해 남성호르몬 박탈 치료와 근치적 전립선적출술의 비용을 비교하였다.
Methods: 본 연구는 스마트 전립선암 데이터베이스(Smart Prostate Cancer Database)의 전립선암 환자 357명의 데이터와 청구데이터베이스에서 의료비 관련 데이터를 도출하였다. 근치적 전립선적출술과 남성호르몬 박탈 치료간 비교를 위해 독립표본 t검정을 실시하였다. 또한 남성호르몬 박탈 치료와 근치적 전립선적출술에 영향을 미치는 요인을 검증하기 위해 다중회귀 분석을 실시하였다.
Findings: 치료 후 1년까지 남성호르몬 박탈치료가 근치적 전립선적출술 보다 비용이 낮은 것으로 나타났으며, 치료 후 4년까지 낮게 유지되었다. 그러나 4년이 지나면 남성호르몬 박탈 치료의 누적의료비가 근치적 전립선적출술보다 더 유의미하게 높게 나타났다. 환자의 병기가 높거나 나이가 많은 경우 근치적 전립선적출술보다 남성호르몬 박탈 치료를 할 확률이 더 높았다.
Practical Implications: 본 연구는 조기 암 발견이 환자 뿐 아니라 국민건강보험공단의 의료비를 줄일 수 있다는 것을 보여 준다. 또한 의료비를 정확히 평가하기 위해서는 오랜 기간의 정보를 평가해야 하며, 이를 기반으로 평가 및 예측이 필요함을 증명하였다.

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the medical expenditures for prostate cancer patients, including out-of-pocket costs, and compared the costs between androgen deprivation therapy and radical prostatectomy treatment.
Methodology: This study combined clinical data from 357 prostate cancer patients from the Smart Prostate Cancer Database and the medical expenditure data from the claims and cost databases. We used the independent two-sample t-tests to compare androgen deprivation therapy and radical prostatectomy. Multivariable logistic regression analysis was conducted to identify determining factors for androgen deprivation therapy and radical prostatectomy treatments.
Findings: The medical costs of androgen deprivation therapy treatment were much lower than radical prostatectomy treatment at the one year and remained lower until the fourth-year. However, after four years, the accumulated medical expenditures of androgen deprivation therapy become significantly higher than radical prostatectomy treatment. Patients with a higher cancer stage and older age had higher chances of being treated using androgen deprivation therapy treatment than radical prostatectomy treatment.
Practical Implications: Our results show that early detection of cancer reduces the treatment cost for both patients and insurance payers. It also demonstrates that cost comparisons should be conducted over long periods of time in order to most accurately assess the costs.

참고문헌 (Reference)

1 신보성, "남성호르몬 박탈요법을 받은 전립선암 환자의 삶의 질" 대한비뇨기종양학회 14 (14): 10-17, 2016

2 Louis Potters, "Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation" Elsevier BV 71 (71): 29-33, 2004

3 Link RE, "Making ends meet : a cost comparison of laparoscopic and open radical retropubic prostatectomy" 172 (172): 269-274, 2004

4 Kupelian PA., "Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era" 52 (52): 704-711, 2002

5 Heidenreich A, "EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer" 65 (65): 67-79, 2014

6 Yasunaga H, "Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men : a contingent valuation survey" 77 (77): 1325-1329, 2011

7 Choi IY, "Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system" 1 (1): 59-64, 2013

8 Bolenz C, "Costs of radical prostatectomy for prostate cancer : a systematic review" 65 (65): 316-324, 2014

9 Nguyen PL, "Cost implications of the rapid adoption of newer technologies for treating prostate cancer" JCO 1217-, 2011

10 Bolenz C, "Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer" 57 (57): 53-58, 2010

11 Silverstein AD, "Cost comparison of radical retropubic and radical perineal prostatectomy : single institution experience" 63 (63): 746-750, 2004

12 Anderson JK, "Cost comparison of laparoscopic versus radical retropubic prostatectomy" 66 (66): 557-560, 2005

13 Takefumi Satoh, "Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience" Springer Nature 27 (27): 348-354, 2009

14 Sugihara T, "Comparisons of perioperative outcomes and costs between open and laparoscopic radical prostatectomy : A propensity‐score matching analysis based on the Japanese Diagnosis Procedure Combination database" 20 (20): 349-353, 2013

15 김장묵, "Comparison Between Total Knee Arthroplasty and MCIC (autologous bone marrow mesenchymal-cell-induced-chondrogenesis) for the Treatment of Osteoarthritis of the Knee" 한국조직공학과 재생의학회 11 (11): 405-413, 2014

16 Tomaszewski JJ, "Comparative hospital cost-analysis of open and robotic-assisted radical prostatectomy" 80 (80): 126-129, 2012

17 Rebecca Siegel, "Cancer statistics, 2013" American Cancer Society 63 (63): 11-30, 2013

18 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010" 대한암학회 45 (45): 1-14, 2013

19 허성우, "Autologous Bone Marrow Mesenchymal Cell Induced Chondrogenesis for the Treatment of Osteoarthritis of Knee" 한국조직공학과 재생의학회 13 (13): 200-209, 2016

20 Hohwü L, "A short-term cost-effectiveness study comparing robot-assisted laparoscopic and open retropubic radical prostatectomy" 14 (14): 403-409, 2011